Our continuous pursuit of pioneering innovations and advancements in molecular diagnostics is dedicated to supporting the technology led actionable strategy of At Patient Testing (APT) and improving global health outcomes. APT represents true point of care testing whilst the patient waits (human or animal) in any environment without frontiers.
